US-based Varian Medical Systems has purchased clinical decision support (CDS) software provider Evinance Innovation to acquire clinical workflow, decision support, and adherence tracking capabilities for cancer care.
The financial details of the acquisition have not been disclosed. The deal is said to be part of Varian’s long-term strategy to boost its position in multi-disciplinary integrated cancer care solutions.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Intended to bolster Varian’s 360 Oncology care management platform, the Evinance Decision Support solution provides access to the latest clinical information to enable clinicians to make treatment decisions based on evidence.
Varian Oncology Systems business president Kolleen Kennedy said: “With healthcare reimbursement models moving to value-based patient care, it is critical for clinicians to be equipped with the tools that make it easier for them to provide evidence-based and coordinated care consistently across clinical settings.”
The firm will integrate Evinance’s platform within its 360 Oncology to offer visual care pathways and compliance tracking.
The integrated solution will allow clinicians to simultaneously visualise a patient’s journey and apply evidence-based guidelines.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataKennedy added: “With this acquisition and integration of the Evinance platform into 360 Oncology, we are moving closer to our goal of delivering a comprehensive cancer care operating system that helps clinicians make more informed decisions at the point of care.”
Varian designed 360 Oncology as a comprehensive, single platform connecting hospital or clinic data, records, and patient information for more coordinated care.
